These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2160793)

  • 1. Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential.
    Johnson KM; Jones SM
    Annu Rev Pharmacol Toxicol; 1990; 30():707-50. PubMed ID: 2160793
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists.
    Olney JW; Price MT; Labruyere J; Salles KS; Frierdich G; Mueller M; Silverman E
    Eur J Pharmacol; 1987 Oct; 142(2):319-20. PubMed ID: 2826182
    [No Abstract]   [Full Text] [Related]  

  • 3. High correlation between the localization of [3H]TCP binding and NMDA receptors.
    Maragos WF; Chu DC; Greenamyre JT; Penney JB; Young AB
    Eur J Pharmacol; 1986 Apr; 123(1):173-4. PubMed ID: 3011454
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants of affinity for the phencyclidine binding site of the N-methyl-D-aspartate receptor complex: discovery of a rigid phencyclidine analogue of high binding affinity.
    Kozikowski AP; Pang YP
    Mol Pharmacol; 1990 Mar; 37(3):352-7. PubMed ID: 2156150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncompetitive N-methyl-D-aspartate antagonists affect multiple ionic currents.
    Rothman S
    J Pharmacol Exp Ther; 1988 Jul; 246(1):137-42. PubMed ID: 2455788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
    Goldberg MP; Viseskul V; Choi DW
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1081-7. PubMed ID: 2838603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular target size of NMDA antagonist binding sites.
    Honoré T; Drejer J; Nielsen M; Watkins JC; Olverman HJ
    Eur J Pharmacol; 1987 Apr; 136(1):137-8. PubMed ID: 3036542
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia.
    Albers GW
    Clin Neuropharmacol; 1990 Jun; 13(3):177-97. PubMed ID: 1972652
    [No Abstract]   [Full Text] [Related]  

  • 10. A phencyclidine recognition site is associated with N-methyl-D-aspartate inhibition of carbachol-stimulated phosphoinositide hydrolysis in rat cortical slices.
    Gonzales RA; Moerschbaecher JM
    Mol Pharmacol; 1989 Jun; 35(6):787-94. PubMed ID: 2543912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
    Bennett DA; Bernard PS; Amrick CL; Wilson DE; Liebman JM; Hutchison AJ
    J Pharmacol Exp Ther; 1989 Aug; 250(2):454-60. PubMed ID: 2547931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turning behavior induced by phencyclidine: relationship to antagonism of N-methyl-D-aspartate in the rat striatum.
    Johnson KM; Snell LD
    NIDA Res Monogr; 1986; 67():235-41. PubMed ID: 3092071
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands.
    Sircar R; Samaan H; Nichtenhauser R; Snell LD; Johnson KM; Rivier J; Vale W; Zukin RS; Zukin SR
    NIDA Res Monogr; 1986; 75():157-60. PubMed ID: 2828962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
    Carter CJ; Lloyd KG; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of phencyclidine receptors by excitatory amino acid receptor ligands.
    Javitt DC; Zukin SR
    Psychopharmacol Bull; 1988; 24(3):444-9. PubMed ID: 2856419
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral pathways activated by PCP-like compounds: relevance to neurotransmitters and their receptors.
    Piercey MF; Hoffmann WE
    NIDA Res Monogr; 1989; 95():264-9. PubMed ID: 2577033
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral pharmacology of PCP, NMDA and sigma receptors.
    Balster RL
    NIDA Res Monogr; 1989; 95():270-4. PubMed ID: 2561831
    [No Abstract]   [Full Text] [Related]  

  • 18. Cycloleucine competitively antagonizes the strychnine-insensitive glycine receptor.
    Snell LD; Johnson KM
    Eur J Pharmacol; 1988 Jun; 151(1):165-6. PubMed ID: 2843389
    [No Abstract]   [Full Text] [Related]  

  • 19. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
    Rothman RB; Reid AA; Monn JA; Jacobson AE; Rice KC
    Mol Pharmacol; 1989 Dec; 36(6):887-96. PubMed ID: 2557536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research.
    Zukin SR; Javitt DC
    NIDA Res Monogr; 1989; 95():247-54. PubMed ID: 2561829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.